Clin2
NCT06475105Possibly a fitRecruiting

Acetazolamide and Furosemide for Acute Heart Failure

Acute Decompensated Heart Failure

Part of Heart & circulation clinical trials.

This trial tests whether adding an oral water pill (acetazolamide) to standard IV furosemide helps people with acute heart failure who have fluid overload. It aims to see if the combination improves outcomes better than furosemide alone.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
66 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have acute heart failure with signs of fluid overload (swelling, fluid in belly, or lungs).
  • You are already taking at least 40 mg of furosemide (water pill) daily for at least a month.
  • Your NT-proBNP level (a heart stress marker) is high (over 300 pg/mL or age-adjusted).
  • You do not have a recent heart attack or unstable angina.
  • Your kidney function is not very low (eGFR above 20).
  • You are not pregnant, breastfeeding, or on dialysis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07199088Recruiting
Comparing two medicines for fluid buildup in heart failure

This study tests whether adding acetazolamide or metolazone to standard treatment helps remove extra fluid better in people hospitalized for heart failure. It aims to find a safer and more effective option for managing fluid overload.

Chak Four Hundred Fifty-four, Punjab Province
NCT06414759Recruiting· Phase 4
Combination diuretic therapy for heart failure fluid overload

This trial tests a combination of water pills (diuretics) to help remove extra fluid in people hospitalized with acute decompensated heart failure (sudden worsening of heart failure). It aims to find a safe and effective way to reduce swelling and fluid buildup.

Giza, GZ
NCT06898515Recruiting· Phase 3
Fluid removal study for acute heart failure patients

This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).

Irvine, California
NCT07372040Recruiting· Phase 2
Adding a Water Pill for Heart Failure in the Hospital

This trial tests if adding a diuretic (water pill) called acetazolamide to usual care can help you get rid of extra fluid faster while you are in the hospital for worsening heart failure.

Tanta
NCT06535529Recruiting· Phase 3
Comparing Two Water Pills for Worsening Heart Failure

This study compares two medicines—acetazolamide and dapagliflozin—to see which works better at removing extra fluid in people hospitalized for worsening heart failure. It may help decide the best treatment for fluid overload.

Cairo
NCT07737964Not yet recruiting· Phase 3
Acetazolamide to help heart failure patients lose fluid and feel better

This trial tests if adding acetazolamide (a water pill) to your usual heart failure treatment can help you lose extra fluid and relieve symptoms. It is for patients recently hospitalized or seen urgently for heart failure worsening.

Amiens

Hear when a new Acute Decompensated Heart Failure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.